Skip to Main Content

header search

search input Search input auto suggest

Search

Menu

About
Issues
Editorial Info
Contributors
Contact
- Feedback and Support
- Advertising
CPNP

Skip Nav Destination

Issues

Select Year

Select Issue

Volume 6, Issue 2

1 March 2016

eISSN 2168-9709

In this Issue

CLINICAL PEARL
ORIGINAL RESEARCH
Literature Review
INNOVATIVE PRACTICE

Personality Disorders / Open Submissions, Vol. 6, Iss. 2

CLINICAL PEARL

Dialectical behavior therapy as treatment for borderline personality disorder

Jennifer M May, MD; Toni M Richardi, PsyD; Kelly S Barth, DO

Identification, assessment, and management of pain in patients with advanced dementia

Kasey L. Malotte, PharmD, BCPS; Mary Lynn McPherson, PharmD, MA, BCPS, CPE

ORIGINAL RESEARCH

Psychotropic medication use in hospitalized patients with borderline personality disorder

Karen E Moeller, PharmD, BCPP; Amad Din, MD, MPH; Macey Wolfe, PharmD; Grant Holmes, PharmD

A consumer-led intervention to improve pharmacists' attitudes toward mental illness

Nathaniel M. Rickles, PharmD, PhD, BCPP; Alison DaCosta, PharmD

Literature Review

Review of pharmacologic treatment in cluster A personality disorders

Jessa Koch, PharmD; Taylor Modesitt, PharmD; Melissa Palmer, PharmD; Sarah Ward, PharmD; Bobbie Martin, PharmD, BCPP; Robby Wyatt, MD; Christopher Thomas, PharmD, BCPP, BCPS

Second-generation antipsychotic use in borderline personality disorder: What are we targeting?

Adrian Wasylyshen; Andrew M. Williams, PharmD, BCPP

INNOVATIVE PRACTICE

A design and focus group evaluation of dietary choices tools for an underserved population

Tressa McMorris, PharmD; Gary Sweet, Jr, PharmD Candidate; Christopher J. Sullivan, PharmD Candidate; Nicole B. Washington, DO; Nancy Brahm, PharmD, MS, BCPP, CGP

Suicide prevention in pharmaceutical education: Raising awareness with inspiring stories

Philippe D. Vincent, BPharm, MSc, BCPP; Pierre-Marie David, PharmD, PhD

Cover Image

Cover Image

Latest
Most Read

Best practice model for outpatient psychiatric pharmacy practice, part 2: Confirmation of the attribute statements

Kelly C. Lee, PharmD, MAS, BCPP, Richard J. Silvia, PharmD, BCPP, Gregory H. Payne, MBA, Tera D. Moore, PharmD, BCACP, Elayne D. Ansara, PharmD, BCPS, BCPP, Clint A. Ross, PharmD, BCPP

Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements

Richard J. Silvia, PharmD, BCPP, Kelly C. Lee, PharmD, MAS, BCPP, Gregory H. Payne, MBA, Jessica Ho, PharmD, BCPS, BCPP, Carla Cobb, PharmD, BCPP, Elayne D. Ansara, PharmD, BCPS, BCPP, Clint A. Ross, PharmD, BCPP

Positioning psychiatric pharmacists to improve mental health care

Julie A. Dopheide, PharmD, BCPP, FASHP, Amy Werremeyer, PharmD, BCPP, Robert J. Haight, PharmD, BCPP, Cynthia A. Gutierrez, PharmD, MS, BCPP, Andrew M. Williams, PharmD, BCPP

CPNP 2022 Annual Meeting Poster Abstracts

Ambitious AAPP vision necessitates bold actions

Marshall E. Cates, PharmD, BCPP, FASHP, FCCP, FALSHP, Cherry W. Jackson, PharmD, FASHP, FCCP, BCPP

About
Issues
Advertising
Facebook

Twitter
LinkedIn
Permissions

eISSN 2168-9709

Privacy Policy
Get Adobe Acrobat Reader
Support

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept